The clinical outcome and risk factors analysis of immune checkpoint inhibitor-based treatment in lung adenocarcinoma patients with brain metastases

BACKGROUND: The data about efficacy of immunotherapy for non-small cell lung cancer with brain metastases (BMs) from real-word settings are controversial. This real-word study is aimed to evaluate the clinical outcome of immune checkpoint inhibitor (ICI)-based treatment in lung adenocarcinoma patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Juan, Wu, Yinfei, Xie, Mengqing, Fang, Yujia, Zhao, Jing, Lee, Sung Yong, Im, Yunjoo, Ye, Lingyun, Su, Chunxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073749/
https://www.ncbi.nlm.nih.gov/pubmed/35529783
http://dx.doi.org/10.21037/tlcr-22-260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073749/
https://www.ncbi.nlm.nih.gov/pubmed/35529783
http://dx.doi.org/10.21037/tlcr-22-260

Ejemplares similares